Dustin R. Carr, PharmD, BCPS, AAHIVP
Clinical Pharmacy Specialist, Infectious Diseases
Education and Training
PharmD, Ferris State University, Big Rapids, MI (2014)
PGY1 Pharmacy Practice Residency, Louis Stokes Cleveland VA Medical Center, Cleveland, OH (2015)
PGY2 Infectious Diseases Residency, Wake Forest Baptist Health, Winston-Salem, NC (2016)
American College of Clinical Pharmacy
Society of Infectious Diseases Pharmacists
Clinical and Research Interests
Dr. Carr’s clinical and research interests include antimicrobial resistance, antimicrobial stewardship, management of Staphylococcus aureus infections, and antimicrobial dosing in obesity.
- Carr DR, Bonomo RA, Stiefel U, Sims SV. Cefazolin versus ceftriaxone for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia in a tertiary-care VA medical center. Open Forum Infect Dis. 2015;2(1):620.
- Carr DR, Johnson JW, Wilkin AM, Gibbs HG, Williamson JC. Outcomes of tenofovir discontinuation among HIV-infected patients with suspected tenofovir-associated nephrotoxicity. Open Forum Infect Dis. 2016;3(1):2183.